Analysis of Regional Timelines To Set Up a Global Phase III Clinical Trial in Breast Cancer: The Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Experience

PURPOSE. This study measured the time taken for setting up the different facets of Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization (ALTTO), an international phase III study being conducted in 44 participating countries. METHODS. Time to regulatory authority (RA) approval, time to ethics...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Metzger-Filho, Otto, de Azambuja, Evandro, Bradbury, Ian, Saini, Kamal S., Bines, José, Simon, Sergio D., Dooren, Veerle Van, Aktan, Gursel, Pritchard, Kathleen I., Wolff, Antonio C., Smith, Ian, Jackisch, Christian, Lang, Istvan, Untch, Michael, Boyle, Frances, Xu, Binghe, Baselga, Jose, Perez, Edith A., Piccart-Gebhart, Martine
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Breast Cancer
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3579596/
https://ncbi.nlm.nih.gov/pubmed/23359433
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0342
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados